Medidata debuts Protocol Optimization at ASCO

Medidata announced the launch of Medidata Protocol Optimization, part of the Medidata Study Experience which is available on the Medidata Platform. Medidata is showcasing this novel solution at the American Society of Clinical Oncology 2025 conference, which will be held from May 30-June 3, 2025 in Chicago. Medidata Protocol Optimization, a flagship component of the unified Study Experience, transforms trial design and execution by leveraging AI-driven predictive modeling, digital protocols, and industry-leading aggregated data to simulate trial performance. This solution has the ability to predict the impact on patient burden, site performance, and costs, well in advance of the First Patient In resulting in research teams gaining critical foresight into the potential challenges. This approach significantly decreases costly amendments and enrollment delays, leading to smoother and lower cost trials.